Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-
- CAS No.
- 2748157-34-6
- Chemical Name:
- Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-
- Synonyms
- 2-(1-(cyclohexylmethyl)-1H-indazole-3-carboxamido)-3-methylsuccinicacid;Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-
- CBNumber:
- CB813187534
- Molecular Formula:
- C20H25N3O5
- Molecular Weight:
- 387.43
- MDL Number:
- MOL File:
- 2748157-34-6.mol
| Product description | Number | Pack Size | Price |
| AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 17084 | 500 μg | $117 |
| AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 17084 | 1 mg | $222 |
| AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 17084 | 5 mg | $923 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() ![]() ![]() GHS02,GHS06,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H225-H301+H311+H331-H370 | |||||||||
| Precautionary statements | P210-P240-P241-P242-P243-P260-P264-P270-P271-P280-P301+P310-P321-P330-P303+P361+P353-P304+P340-P307+P311-P312-P361+P364-P370+P378-P403+P233-P403+P235-P405-P501 | |||||||||
| NFPA 704 |
|
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 17084 | AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 2748157-34-6 | 500 μg | $117 | 2024-03-01 | Buy |
| Cayman Chemical | 17084 | AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 2748157-34-6 | 1 mg | $222 | 2024-03-01 | Buy |
| Cayman Chemical | 17084 | AB-CHMINACA metabolite M7 ≥95% (mixture of diastereomers) | 2748157-34-6 | 5 mg | $923 | 2024-03-01 | Buy |
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Chemical Properties,Uses,Production
Description
AB-CHMINACA is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA , a potent agonist of the central CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M7 is a potential metabolite produced during metabolism of AB-CHMINACA in vivo. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
References
1. Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives ,1-283(2009).
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Preparation Products And Raw materials
Raw materials
Preparation Products
Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Cayman Chemical Company | 800-364-9897 | sales@caymanchem.com | China | 6838 | 58 |
| Supplier | Advantage |
|---|---|
| Cayman Chemical Company | 58 |







